Since modern medicine began treating cancer with drugs, the foundations of cancer treatment were threefold: surgery, chemotherapy, and radiation therapy. Over the last two decades, targeted therapies like imatinib (Gleevec®) and trastuzumab (Herceptin®) —drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells—have also been added as standard treatments for some cancers.

Over the past several years, immunotherapy—therapies that disable the body’s normal response to not attack self-tissue has emerged as what many in the cancer community now call the “fifth pillar” of cancer treatment. Immunotherapy, like other promising solutions doesn’t work for many cancers. Now, Car -T-cell Therapy, a new, emerging hope in the industry shows a lot of promise in initial trials

Listen to more here: